Yue-yong C. Zhu - Publications

Clinical features and long-term outcomes of patients with ZFYVE19 variants.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: September 03, 2024

Case report: ZFYVE19 gene mutation is associated with familial cholestasis.

Journal: Frontiers in medicine

Published: March 13, 2024

Metabolic dysfunction-associated fatty liver disease increases the risk of complications after radical resection in patients with hepatocellular carcinoma.

Journal: World journal of surgical oncology

Published: December 11, 2023

Diagnostic value of liver stiffness measurement combined with risk scores for esophagogastric variceal bleeding in patients with hepatitis B cirrhosis.

Journal: European journal of radiology

Published: October 10, 2023

Varied immune responses of HBV-specific B cells in patients undergoing pegylated interferon-alpha treatment for chronic hepatitis B.

Journal: Journal of hepatology

Published: September 30, 2023

A novel small-animal locomotor activity recording device for biological clock research.

Journal: Animal models and experimental medicine

Published: September 03, 2023

Tenofovir alafenamide significantly increased serum lipid levels compared with entecavir therapy in chronic hepatitis B virus patients.

Journal: World journal of hepatology

Published: March 20, 2023

Liver Stiffness Measurement can Predict Liver Inflammation in Chronic Hepatitis B Patients with Normal Alanine Transaminase.

Journal: Journal of clinical and translational hepatology

Published: July 14, 2022

Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changes.

Journal: World journal of gastroenterology

Published: April 12, 2022

Gasdermin D Inhibitor Necrosulfonamide Alleviates Lipopolysaccharide/D-galactosamine-induced Acute Liver Failure in Mice.

Journal: Journal of clinical and translational hepatology

Published: December 13, 2021

The impact of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with hepatocellular carcinoma after radical resection.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: August 15, 2021

Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease.

Journal: World journal of gastroenterology

Published: January 06, 2021